Dec 16 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCES STRATEGIC EQUITY
INVESTMENT OF
EUR 7.5 MILLION BY JOHNSON & JOHNSON INNOVATION
* PURSUANT TO THE AGREEMENT, JJDC WILL SUBSCRIBE TO
5,357,142 NEW
ORDINARY MKEA SHARES FOR €1.40 PER SHARE, REPRESENTING A TOTAL
EQUITY VALUE OF 7.5 MILLION EURO.
* NEW ORDINARY SHARES WILL BE FUNGIBLE WITH EXISTING SHARES
OF
COMPANY
* JJDC WILL OWN APPROXIMATELY 17.5% OF TOTAL ORDINARY SHARES
OUTSTANDING FOLLOWING THIS TRANSACTION
* JJDC WILL NOT HAVE ANY BOARD REPRESENTATION RIGHTS
* NET PROCEEDS WILL BE USED TO FURTHER DEVELOP THE CELLVIZIO
PLATFORM, PURSUE CLINICAL STUDIES AND INTENSIFY SALES AND
MARKETING EFFORTS IN THE UNITED STATES
* EXPECTS NET PROCEEDS FROM THE SHARE CAPITAL INCREASE,
COMBINED
WITH ITS CURRENT OPERATING CAPITAL, TO ENABLE THE FUNDING OF ITS
OPERATIONS UNTIL THE END OF 2020
* AS PART OF INVESTMENT, JJDC AGREED TO CUSTOMARY LOCK UP
AND
STAND STILL OBLIGATIONS FOR A PERIOD OF 12 MONTHS
* PIPER JAFFRAY IS ACTING AS STRATEGIC ADVISOR AND MCDERMOTT
WILL
& EMERY IS ACTING AS LEGAL ADVISOR TO MAUNA KEA TECHNOLOGIES
* CLOSING OF TRANSACTION IS EXPECTED TO OCCUR ON DECEMBER
19, 2019
Source text for Eikon: ID:nBw3lDc40a
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))